Skip to main content
Chase Science Co.,Ltd logo

Chase Science Co.,Ltd — Investor Relations & Filings

Ticker · 300941 ISIN · CNE100004CZ0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 514 across all filing types
Latest filing 2021-02-03 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300941

About Chase Science Co.,Ltd

https://www.echase.cn

Chase Science Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical puncture instruments and laboratory consumables. The company's core product portfolio includes a wide range of medical devices such as safety syringes, insulin syringes, hypodermic needles, and infusion sets designed for clinical use. Additionally, the firm produces specialized veterinary medical instruments and laboratory plasticware. Chase Science emphasizes the integration of safety-engineered technologies into its products to minimize needle-stick injuries and enhance patient care. With a focus on high-precision manufacturing and international quality standards, the company serves a global market, providing essential medical supplies to healthcare facilities and research institutions. Its operations are characterized by a commitment to technological innovation in the field of medical consumables and puncture technology.

Recent filings

Filing Released Lang Actions
首次公开发行股票并在创业板上市发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行结果公告" which translates to "Issuance Results Announcement" for the company's initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It details the final issuance numbers, subscription statistics, pricing, allocation between online and offline investors, lock-up periods, underwriting arrangements, and contact information for the sponsoring underwriter. The document is an announcement of the results of a capital raising event (IPO) rather than a full financial report or prospectus. It does not contain financial statements or management discussion but focuses on the outcome of the share issuance and subscription process. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 3,035 characters, consistent with an announcement rather than a full report. Confidence is high given the clear content and terminology related to share issuance results.
2021-02-03 Chinese
首次公开发行股票并在创业板上市招股说明书
Regulatory Filings Classification · 95% confidence The document is titled '招股说明书' which translates to 'Prospectus' or 'IPO Prospectus'. It contains detailed information about the company's initial public offering (IPO) on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). The text includes sections on investment risks, issuance details, financial data, governance, business overview, risk factors, and legal commitments. It is a comprehensive disclosure document prepared for the purpose of a stock issuance and listing, typical of an IPO prospectus. This type of document is not an annual report, earnings release, or any other category listed. It is a regulatory filing specific to the IPO process. Given the detailed nature and the context, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings including IPO prospectuses that do not fit other categories.
2021-02-03 Chinese
首次公开发行股票并在创业板上市网上摇号中签结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an announcement of the lottery results for the initial public offering (IPO) of shares of Fujian Chuangshi Technology Co., Ltd. It details the winning numbers for the online subscription lottery and instructions for investors regarding payment obligations. The document is short (1975 characters) and focuses on the announcement of lottery results related to the IPO subscription process. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement related to capital issuance and subscription results. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-02-01 Chinese
首次公开发行股票并在创业板上市网下初步配售结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票并在创业板上市网下初步配售结果公告" which translates to "Initial Offline Placement Results Announcement for the Initial Public Offering and Listing on the ChiNext Board". It details the allocation results of shares in an IPO, including pricing, allocation to investors, subscription details, and payment instructions. It is an announcement of the results of the IPO share allocation, not the IPO prospectus or a financial report. The document is lengthy (15,000 characters) but is focused on the announcement of the allocation results and instructions related to the IPO issuance. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs and share issuance. It is not a full financial report, earnings release, nor a regulatory filing or report publication announcement. Therefore, the best classification is CAP with high confidence.
2021-02-01 Chinese
首次公开发行股票并在创业板上市网上申购情况及中签率公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) of shares by 福建创识科技股份有限公司, detailing the online subscription situation and the lottery results for share allocation. It includes information about the number of shares issued, pricing, subscription procedures, allotment ratios, and the timing of payment obligations. The document is not a financial report, earnings release, or management discussion but rather a formal announcement related to the share issuance process and subscription results. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital market activities.
2021-01-31 Chinese
首次公开发行股票并在创业板上市投资风险特别公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票并在创业板上市投资风险特别公告" which translates to "Initial Public Offering (IPO) and Listing on the Growth Enterprise Market - Special Investment Risk Announcement." It discusses the IPO pricing, allocation, subscription process, risk factors, and regulatory approvals related to the company's first public stock issuance and listing on the Shenzhen Stock Exchange's Growth Enterprise Market. The content focuses on investment risks, pricing rationale, subscription rules, and regulatory compliance for the IPO. It does not contain financial statements, audit opinions, management discussions, or earnings data. It is not a full annual or interim report, nor a call transcript or management report. It is an announcement specifically about the investment risks related to the IPO process. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2021-01-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.